Renal Angiomyolipoma
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. (NCT03525834) | Novartis Pharmaceuticals | 2018-11-09 |
| Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) (NCT02654340) | CENTOGENE GmbH Rostock | 2018-08-01 |
Track Renal Angiomyolipoma automatically
Every clearance here is in the API, with alerts when new ones post.